Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens - Kitazawa, T; Esaki, K; Tachibana, T (Thromb Haemost, 2017)